Kolon TissueGene, Inc.
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
950160 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840120008
- LEI:
- Country:
- United States of America
- Address:
- 9713 Key West Ave Suite 300, Rockville
- Website:
- https://www.tissuegene.com/
- Sector:
- Manufacturing
Description
Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-24 00:00 |
[기재정정]사업보고서 (2020.12)
|
Korean | 1.3 MB | ||
| 2021-03-24 00:00 |
[기재정정]감사보고서제출
|
Korean | 21.6 KB | ||
| 2021-03-24 00:00 |
[기재정정]사업보고서 (2020.12)
|
Korean | 1.3 MB | ||
| 2021-03-23 00:00 |
감사보고서제출
|
Korean | 18.4 KB | ||
| 2021-03-23 00:00 |
사업보고서 (2020.12)
|
Korean | 1.2 MB | ||
| 2021-03-15 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2021-03-15 00:00 |
주주총회소집공고
|
Korean | 115.7 KB | ||
| 2021-02-15 00:00 |
주주총회소집결의
|
Korean | 9.4 KB | ||
| 2021-01-21 00:00 |
[기재정정]감사보고서제출(2017사업연도)
|
Korean | 24.5 KB | ||
| 2021-01-21 00:00 |
[기재정정]감사보고서제출(2018사업연도)
|
Korean | 26.6 KB | ||
| 2021-01-21 00:00 |
[기재정정]감사보고서제출(2019사업연도)
|
Korean | 25.7 KB | ||
| 2021-01-21 00:00 |
[기재정정]사업보고서 (2017.12)
|
Korean | 1.3 MB | ||
| 2021-01-21 00:00 |
[기재정정]사업보고서 (2018.12)
|
Korean | 1.3 MB | ||
| 2021-01-21 00:00 |
[기재정정]사업보고서 (2019.12)
|
Korean | 1.3 MB | ||
| 2020-12-17 00:00 |
기타경영사항(자율공시)(제22기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
|
Korean | 4.6 KB |
Automate Your Workflow. Get a real-time feed of all Kolon TissueGene, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kolon TissueGene, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kolon TissueGene, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
